121 related articles for article (PubMed ID: 10147051)
21. Issues related to monitoring the safety of over-the-counter (OTC) medicines.
Bond C; Hannaford P
Drug Saf; 2003; 26(15):1065-74. PubMed ID: 14640771
[TBL] [Abstract][Full Text] [Related]
22. Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom.
Ryan M; Yule B
Health Policy; 1990 Dec; 16(3):233-9. PubMed ID: 10113545
[TBL] [Abstract][Full Text] [Related]
23. A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches.
Fisher M; Rawal K
Ther Innov Regul Sci; 2023 Sep; 57(5):1074-1080. PubMed ID: 37357243
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
25. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
Simoni-Wastila L; Stuart BC; Shaffer T
J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
[TBL] [Abstract][Full Text] [Related]
26. Patients, society, and the increase in self medication.
Blenkinsopp A; Bradley C
BMJ; 1996 Mar; 312(7031):629-32. PubMed ID: 8595343
[TBL] [Abstract][Full Text] [Related]
27. Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM.
Kühler TC; Ateka A; Lassoued Z; Routhier FX; Mékary-Sawaya S
Clin Ther; 2024 Mar; 46(3):208-216. PubMed ID: 38278703
[TBL] [Abstract][Full Text] [Related]
28. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
29. New OTC drugs and devices 2001: a selective review.
Newton GD; Benninghoff AJ; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2002; 42(2):267-77. PubMed ID: 11926667
[TBL] [Abstract][Full Text] [Related]
30. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
Duijmelinck DM; Mosca I; van de Ven WP
Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
[TBL] [Abstract][Full Text] [Related]
31. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
Sullivan PW; Follin SL; Nichol MB
Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671
[TBL] [Abstract][Full Text] [Related]
32. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
[TBL] [Abstract][Full Text] [Related]
33. Potential public sector cost-savings from over-the-counter access to oral contraceptives.
Foster DG; Biggs MA; Phillips KA; Grindlay K; Grossman D
Contraception; 2015 May; 91(5):373-9. PubMed ID: 25732570
[TBL] [Abstract][Full Text] [Related]
34. Cost impact of switching histamine(2)-receptor antagonists to nonprescription status.
Furler MD; Rolnick MS; Lawday KS; Mak MW; Einarson TR
Ann Pharmacother; 2002; 36(7-8):1135-41. PubMed ID: 12086543
[TBL] [Abstract][Full Text] [Related]
35. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
Kohli E; Buller A
South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
[TBL] [Abstract][Full Text] [Related]
37. The drugs don't sell: DIY heart health and the over-the-counter statin experience.
Will CM; Weiner K
Soc Sci Med; 2015 Apr; 131():280-8. PubMed ID: 24954520
[TBL] [Abstract][Full Text] [Related]
38. Assessing student pharmacist impact on patient over-the-counter medication selection.
McConaha JL; Finoli LM; Heasley JE; Lunney PD
J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
[TBL] [Abstract][Full Text] [Related]
39. Rx-to-OTC switches: trends and factors underlying success.
Mahecha LA
Nat Rev Drug Discov; 2006 May; 5(5):380-5. PubMed ID: 16604099
[TBL] [Abstract][Full Text] [Related]
40. Pharmacists' evaluations of the nonprescription availability of metaproterenol, cimetidine, ibuprofen, and nystatin.
Madhavan S; Schondelmeyer SW
Am J Hosp Pharm; 1989 Dec; 46(12):2486-92. PubMed ID: 2603883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
